SEC Company Response from Park Ha Biological Technology Co., (BYAH) — Dec 22, 2025
Park Ha Biological Technology Co., Ltd.
Date: Dec. 22, 2025 · CIK: 0001986247 · Accession: 0001213900-25-124118
AI Filing Summary & Sentiment
File numbers found in text: 333-290410
Show Raw Text
CORRESP 1 filename1.htm Park Ha Biological Technology Co., Ltd. 901, Building C Phase 2, Wuxi International Life Science Innovation Campus 196 Jinghui East Road Xinwu District, Wuxi, Jiangsu Province People's Republic of China 214000 December 22, 2025 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Robert Augustin Re: Park Ha Biological Technology Co., Ltd. Registration Statement on Form F-1, as amended (File No. 333-290410) Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Park Ha Biological Technology Co., Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on Wednesday, December 24, 2025, or as soon as thereafter practicable. Very truly yours, Park Ha Biological Technology Co., Ltd. /s/ Xiaoqiu Zhang Name: Xiaoqiu Zhang Title: Chief Executive Officer and Director